Strategic alliances influence on small and medium firm performance

Journal of Business Research

Volumn 60, Issue 7, 2007, Pages 731-741

  Lee, Cheng Wen ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Biotech new venture; SMEs; Strategic alliance

Indexed keywords

EID: 34248512240     PISSN: 01482963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbusres.2007.02.018     Document Type: Article

References (68)

1. Anderson E.W., Fornell C., and Donald R.L. Customer satisfaction, market share and profitability: findings from Sweden. J Mark 58 3 (1994) 53-66
2. Anderson J.C., and Narus J.A. A model of distributor firm and manufacturer firm working partnerships. J Mark 24 1 (1990) 42-58
3. Arrow K.J. Economic welfare and the allocation of resources for invention. In: Nelson R.R. (Ed). The rate and direction of inventive activity: economic and social factors (1962), Princeton University Press, NJ
4. Barley S.R., Freeman J., and Hybels R.C. Strategic alliance in commercial biotechnology. In: Nohria N., and Eccles R.G. (Eds). Networks and organizations (1992), Harvard Business School Press, Cambridge, MA
5. Baum J.A.C., Calabrese T., and Silverman B.S. Don't go it alone: alliance network composition and startups' performance in Canadian biotechnology. Strateg Manage J 21 3 (2000) 267-294
6. Baum J.A.C., and Oliver C. Institutional linkages and organizational mortality. Adm Sci Q 36 2 (1991) 187-218
7. Bentler P.M. EQS structural equation program manual (1995), BMDP Statistical Software, Los Angles
8. Biggadike R.E. Corporate diversification: entry, strategy and performance (1979.), Harvard University Press, Boston, Mass.
9. Blau P.M. Exchange and power in social life (1964), John Wiley and Sons, New York
10. Bogner W.C., Thomas H., and McGee J. A longitudinal study of the competitive positions and entry paths of European firms in the U.S. pharmaceutical market. Strateg Manage J 17 2 (1996) 85-107
11. Chatman E.A. Channels to a larger social world: older women staying in contact with the great society. Libr Inf Sci Res 13 3 (1991) 281-300
12. Cohen W.M., and Levinthal D.A. Absorptive capacity: a new perspective on learning and innovation. Adm Sci Q 35 (1990) 128-152
13. Coombs J.E., and Deeds D.L. International alliances as sources of capital: evidence from the biotechnology industry. J High Technol Managem Res 11 2 (2000) 235-253
14. Cooper R.G., and Kleinschmidt E.J. New product performance: keys to success, profitability and cycle time reduction. J Market Manag 11 (1995) 315-337
15. Doney P.M., and Cannon J.P. An examination of the nature of trust in buyer-seller relationships. J Mark 61 (1997) 31-55
16. Dwyer F.R., Schun P.H., and Oh S. Developing buyer-seller relationships. J Mark 51 2 (1987) 11-27
17. Etgar M. Sources and types of intrachannel conflict. J Retail 55 1 (1979) 61-78
18. Gassel K., and Pascha W. Milking partners or symbiotic know-how enhancement? International versus national alliances in Japan's biotech industry. Int Bus Rev 9 (2000) 625-640
19. George G., Zahra S.A., Wheatley K.K., and Kan R. The effects of alliance portfolio characteristics and absorptive capacity on performance: a study of biotechnology firms. J High Technol Managem Res 12 (2001) 205-226
20. Grandstrand O., and Sjolander S.E. Managing innovation in multi-technology corporations. Res Policy 19 1 (1990) 35-60
21. Grant R.M. Toward a knowledge-based theory of the firm. Strateg Manage J 17 Special Issue (1996) 109-123
22. Hagedoorn J. Understanding the rationale of strategic technology partnering: interorganizational modes of cooperation and sectoral differences. Strateg Manage J 14 (1993) 371-385
23. Hair J., Anderson R., Tatham R., and Black W. Multivariate data analysis. 2nd ed. (1992), Macmillan, New York
24. Heide J.B., and John G. Do norms matter in marketing relationships?. J Mark 56 2 (1992) 32-44
25. Homans G. Social behavior as exchange. Am J Sociol 62 (1958) 597-606
26. Kauser S., and Shaw V. International strategic alliances: the impact of behavioral characteristics on success. J Euro-Mark 10 1 (2001) 71-98
27. Kelloway E.K. Using LISREL for structural equation modeling: a researcher's guide (1998), Sage Publications, Thousand Oaks, CA
28. Kim L. Crisis construction and organizational learning: capability building in catching-up at Hyundai Motor. Organ Sci 9 (1998) 506-521
29. Kogut B., Shan W., and Walter G. The make-or-cooperate decision in the context of an industry network. In: Nohria N., and Eccles R.G. (Eds). Networks and organizations: structure, form and action (1992), HBS Press, Boston
30. Kotabe M., and Swan K.S. The role of strategic alliances in high-technology new product development. Strateg Manage J 16 (1995) 621-636
31. Koza M.P., and Lewin A.Y. The co-evolution of strategic alliances. Organ Sci 9 (1998) 255-264
32. Koza M.P., and Lewin A.Y. The co-evolution of strategic alliances. Organ Sci 9 (1998) 255-264
33. Kung S.D., Wong J.T., and Ip N.Y. Biotechnology finds its way to Hong Kong. Int J Biotechnol 2 4 (2000) 355-363
34. Lane P.J., and Lubatkin M. Relative absorptive capacity and interorganizational learning. Strateg Manage J 19 (1998) 461-477
35. Lane P.J., Salk J.E., and Lyles M.A. Absorptive capacity, learning, and performance in international joint ventures. Strateg Manage J 22 (2001) 1139-1161
36. Lee C.W. M&A strategy and technological innovation performance of high-technology firms. Int J Bus Strateg 4 2 (2003) 54-75
37. Lee Jr. K.B., and Burrill G.S. Biotech '95 reform, restructure, renewal (1994), Ernst & Young, Palo Alto, CA
38. Lee Y.H., and Kim D. Development of application execution environment in partitioned systems. Final research report to Honeywell International (1999) Dec.
39. Lerner J., and Merges R.P. The control of technology alliances: an empirical analysis of the biotechnology industry. J Ind Econ 46 (1998) 125-156
40. Liyanage S., and Gluckman P. The determinants of biotechnology innovative capability: the dynamics of knowledge and marketplace. Int J Biotechnol 6 2-3 (2004) 281-300
41. Morgan R.M., and Hunt S.D. The commitment-trust theory of relationship marketing. J Mark 58 (1994) 20-38
42. McCutchen Jr. W.W., and Swamidass P.M. The popular strategic configuration of R&D aggressiveness and research funding in emerging biotech firms: a cluster analysis. J High Technol Managem Res 5 2 (1994) 213-232
43. McCutchen Jr. W.W., and Swamidass P.M. Motivations for strategic alliances in the pharmaceutical/biotech industry: some new findings. J High Technol Managem Res 15 (2004) 197-214
44. Mitchell W. Are more good things better, or will technical and market capabilities conflict when a firm expands?. Ind Corp Change 1 (1992) 327-346
45. Mitchell W., and Singh K. Survival of businesses using collaborative relationships to commercialize complex goods. Strateg Manage J 17 3 (1996) 169-195
46. Mohr J., and Spekman R.E. Characteristics of partnership success: partnership attributes, communication behavior, and conflict resolution techniques. Strateg Manage J 15 2 (1994) 135-152
47. Mowery D.C., Oxley J.E., and Silverman B.S. Technological overlap and interfirm cooperation: implications for the resource-base view of the firm. Res Policy 27 (1998) 507-523
48. Mowery D.C., and Rosenberg N. Technology and the pursuit of economic growth (1989), Cambridge University Press, Cambridge
49. Pennings J.M., Barkema H., and Douma S. Organizational learning and diversification. Acad Manage J 37 3 (1994) 608-640
50. Pisano G.P. The R&D boundaries of the firm: an empirical analysis. Adm Sci Q 35 (1990) 356-382
51. Powell W.W. Learning from collaboration, knowledge and networks in the biotechnology and pharmaceutical industries. Calif Manage Rev 40 3 (1998) 228-240
52. Powell W.W., Koput K.W., and Smith-Doerr L. Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology. Adm Sci Q 41 (1996) 116-156
53. Price J.L., and Mueller C.W. Handbook of organizational measurement (1986), Pitman, Marshfield, MA
54. Reuber A.R., and Fischer E. The influence of the management team's international experience on the internationalization behaviors of SMEs. J Int Bus Stud 28 (1997) 807-825
55. Rothaermel F.T. Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry. Res Policy 30 (2001) 1235-1251
56. Rothaermel F.T., and Deeds D.L. Exploration and exploitation alliances in biotechnology: a system of new product development. Strateg Manage J 25 3 (2004) 201-217
57. Sambharya R.B. Foreign experience of top management teams and international diversification strategies of U.S. multinational corporations. Strateg Manage J 17 (1996) 739-746
58. Simonin B.L. The importance of collaborative know-how: an empirical test of the learning organization. Acad Manage J 40 5 (1997) 1150-1174
59. Sivadas E., and Dwyer F.R. An examination of organizational factors influencing new product success in internal and alliance-based processes. J Mark 64 1 (2000) 31-49
60. Sörbom D., and Jöreskog K.G. Recent developments in LISREL: automatic starting values (1982), University of Uppsala, Department of Statistics
61. Stalk G., and Hout T.M. Competing against time (1990), Free Press, New York
62. Szulanski G. Exploring internal stickiness: impediments to the transfer of best practice within the firm. Strateg Manage J 17 Winter Special Issue (1996) 27-43
63. Tripsas M. Unraveling the process of creative destruction: complementary assets xand incumbent survival in the typesetter industry. Strateg Manage J 18 (1997) 119-142
64. Van den Bosch F., Volberda H., and de Boer M. Coevolution of firm absorptive capacity and knowledge environment: organizational forms and combinative capabilities. Organ Sci 10 5 (1999) 551-568
65. Young-Ybarra C., and Wiersema M. Strategic flexibility in information technology alliances: the influence of transaction cost economics and social exchange theory. Organ Sci 10 4 (1999) 439-459
66. Zahra S.A. Technology strategy and new venture performance: a study of corporate-sponsored and independent biotechnology ventures. J Bus Venturing 11 (1996) 289-321
67. Zahra S.A., and George G. Absorptive capacity: a review, reconceptualization and extension. Acad Manage Rev 27 2 (2002) 185-203
68. Ziegelbauer K., and Farquhar R. Strategic alliance management: lessons learned from the Bayer-Millennium collaboration. Drug Discov Today 9 20 (2004) 864-868